Allena Pharmaceuticals Stock Fundamentals
Allena Pharmaceuticals fundamentals help investors to digest information that contributes to Allena Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Allena Pink Sheet. The fundamental analysis module provides a way to measure Allena Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allena Pharmaceuticals pink sheet.
Allena |
Allena Pharmaceuticals Company Shares Owned By Insiders Analysis
Allena Pharmaceuticals' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Allena Pharmaceuticals Shares Owned By Insiders | 0.92 % |
Most of Allena Pharmaceuticals' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allena Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 0.916% of Allena Pharmaceuticals are shares owned by insiders. This is 93.97% lower than that of the Healthcare sector and 93.54% lower than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is 90.92% higher than that of the company.
Allena Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Allena Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Allena Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allena Pharmaceuticals competition to find correlations between indicators driving Allena Pharmaceuticals's intrinsic value. More Info.Allena Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Allena Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Allena Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allena Pharmaceuticals' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Allena Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Allena Pharmaceuticals by comparing valuation metrics of similar companies.Allena Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.
Allena Fundamentals
| Return On Equity | -5.41 | |||
| Return On Asset | -1.07 | |||
| Current Valuation | (181.84 K) | |||
| Shares Outstanding | 122.08 M | |||
| Shares Owned By Insiders | 0.92 % | |||
| Shares Owned By Institutions | 0.26 % | |||
| Number Of Shares Shorted | 10.34 M | |||
| Price To Book | 0.30 X | |||
| EBITDA | (47.29 M) | |||
| Net Income | (48.66 M) | |||
| Cash And Equivalents | 6.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 5.28 M | |||
| Debt To Equity | 1.41 % | |||
| Current Ratio | 1.58 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (45.68 M) | |||
| Short Ratio | 0.62 X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 12 | |||
| Beta | 1.32 | |||
| Market Capitalization | 244.17 K | |||
| Total Asset | 34.76 M | |||
| Z Score | -3.3 | |||
| Net Asset | 34.76 M |
Pair Trading with Allena Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allena Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allena Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Sunoco LP could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sunoco LP when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sunoco LP - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sunoco LP to buy it.
The correlation of Sunoco LP is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sunoco LP moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sunoco LP moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sunoco LP can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Allena Pink Sheet
If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |